News Releases Sona Nanotech to Present at the OTC Markets’ Life Sciences Virtual Investor Forum On September 17th
News Releases Sona Nanotech Closes Over-Subscribed Private Placement Financing to Raise $2,527,012 in Gross Proceeds
News Releases Sona Nanotech Appoints Seasoned Biotech Commercial Executive Michael A. Fleming to Board of Directors
News Releases Sona Nanotech Announces Clinical Strategy With Two THT Combination Therapy Studies In Melanoma
News Releases Sona Nanotech Showcases Cancer Therapy Results At Prestigious Industry Cancer Conferences
News Releases Sona Nanotech Announces Appointment of Two Leading Oncologists To Its Scientific Advisory Board
News Releases Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy Synergies
News Releases Sona Nanotech’s THT Cancer Therapy Demonstrates Strong Efficacy And Durability In Combination with Immunotherapy In Peer-reviewed Preclinical Study
News Releases Sona Nanotech To Hold Investor Webinar To Discuss Follow-up Data From First-in-human Cancer Therapy Study
News Releases Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing
News Releases Sona’s Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study
Media & Interviews Revolutionary Cancer Therapy: Sona Nanotech’s Gold Nanorods Shrink Tumors from the Inside Out
News Releases Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development